1[1]Northway WH , Rosan RC, Portor DY. Pulmonary disease following respirator therapy of hyaline- membrane disease [J]. New Engl J Med, 1967;276:357～368
2[2]Mecolley SA . Bronchopulmonary dysplasia: impact of surfactant replacement therapy [J]. Pediatr Clin North Am, 1998; 45: 573～585
3[3]Cherukupalli K, Larson JE, Rotschild A, et al. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia[J]. Pediatr Pulmonol, 1996;22:215～229
4[4]Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia, current issues[J]. Pediatr Clin North Am,1994;41:277～315
5[5]Warner BB, Stuart LA, Papes RA, et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice[J]. Am J Physiol,1998; 275: L110～117
6[6]Wang EE, Ohlsson A, Kellner JD. Association of ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis[J]. J Pediatr, 1995; 127: 640～ 644
7[7]Niu JO, Munshi UK, Siddiq MM, et al. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia[J]. J Pediatr, 1998; 132:965～970
8[8]Oppenheim C, Mamou MT, Sayegh N, et al. Bronchopulmonary dysplasia: value of CT inidentifying pulmonary sequelae[J]. Am J Roentgenol, 1994; 163:169～ 172
